Experts say there’s no set number of hours, but quality, relevance and ongoing support — returning to the same skills ...

A Good Run: Finding Peace with Parkinson’s By Etana Solomon and Kathleen Camp Premiere at Hopkins School New Haven Saturday, Dec. 13 For Kathleen Camp, 30 to 60 were “the good years.” “It was good. I ...

The TBCRC-056 trial showed a 50% pCR rate in TNBC patients with BRCA or PALB2 mutations treated with niraparib and dostarlimab. sTILs increased significantly in both treatment arms, with higher ...

The event brings together leading experts, patients and care partners for a day of education on navigating the disease.

Paraquat is banned in more than 70 countries, but still legal in the United States. Now, a growing number of U.S. farmers are ...

Most people wait for a visible shake to worry about neurological health, but the disease often starts much earlier with ...

A study of more than 1 million UK medical records found that getting a flu vaccine between ages 40 and 50 did not increase Parkinson’s disease risk and was even associated with a lower estimated ...

Shares of AC Immune rose by double-digits on news that the company, encouraged by new data, now intends to ask drug ...

AC Immune (NASDAQ:ACIU) surged 25% on Thursday after announcing promising interim Phase 2 findings for its experimental Parkinson’s disease treatment, indicating the therapy may help slow the ...

AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s DiseaseResults show, for the ...

An international team led by the University of Michigan has introduced new methods that reveal which regions of the brain were active throughout the day with single-cell resolution.

Discusses Clinical Progress of Lead Drug Candidates Targeting Parkinson's, Alzheimer's, and Liver Disease December 9, 2025 4:15 ...